Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.83 USD | +20.61% | +39.14% | +96.81% |
Jun. 03 | Agios Says of Trial of Blood Disorder Drug Mitapivat Met Primary Endpoint; Shares Rise | MT |
Jun. 03 | Transcript : Agios Pharmaceuticals, Inc. - Special Call |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AGIO Stock
- Revisions Agios Pharmaceuticals, Inc.